| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.16 | 7e-07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-06 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.001 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |